Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancer.

Betts G, Jones E, Junaid S, El-Shanawany T, Scurr M, Mizen P, Kumar M, Jones S, Rees B, Williams G, Gallimore A, Godkin A.

Gut. 2012 Aug;61(8):1163-71. doi: 10.1136/gutjnl-2011-300970. Epub 2011 Dec 29.

2.

Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.

Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.

Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.

PMID:
19022917
3.

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.

Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, Harrop R, Torkington J, Rees BI, Williams GT, Gallimore AM, Godkin AJ.

PLoS One. 2006 Dec 27;1:e129.

4.

Foxp3 expression in CD4+CD25+Foxp3+ regulatory T cells promotes development of colorectal cancer by inhibiting tumor immunity.

Zhu XW, Zhu HZ, Zhu YQ, Feng MH, Qi J, Chen ZF.

J Huazhong Univ Sci Technolog Med Sci. 2016 Oct;36(5):677-682. Epub 2016 Oct 18.

PMID:
27752897
5.

T cell subpopulations in lymph nodes may not be predictive of patient outcome in colorectal cancer.

Kemp RA, Black MA, McCall J, Yoon HS, Phillips V, Anjomshoaa A, Reeve AE.

J Exp Clin Cancer Res. 2011 Aug 24;30:78. doi: 10.1186/1756-9966-30-78.

6.

Intratumoral regulatory T cells are associated with suppression of colorectal carcinoma metastasis after resection through overcoming IL-17 producing T cells.

Wang Q, Feng M, Yu T, Liu X, Zhang P.

Cell Immunol. 2014 Feb;287(2):100-5. doi: 10.1016/j.cellimm.2014.01.002. Epub 2014 Jan 10.

PMID:
24487033
7.

Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.

Saito T, Nishikawa H, Wada H, Nagano Y, Sugiyama D, Atarashi K, Maeda Y, Hamaguchi M, Ohkura N, Sato E, Nagase H, Nishimura J, Yamamoto H, Takiguchi S, Tanoue T, Suda W, Morita H, Hattori M, Honda K, Mori M, Doki Y, Sakaguchi S.

Nat Med. 2016 Jun;22(6):679-84. doi: 10.1038/nm.4086. Epub 2016 Apr 25.

PMID:
27111280
8.

Regulatory T-cell-mediated inhibition of antitumor immune responses is associated with clinical outcome in patients with liver metastasis from colorectal cancer.

Brudvik KW, Henjum K, Aandahl EM, Bjørnbeth BA, Taskén K.

Cancer Immunol Immunother. 2012 Jul;61(7):1045-53. doi: 10.1007/s00262-011-1174-4. Epub 2011 Dec 11.

PMID:
22159472
9.

Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.

Schneider T, Kimpfler S, Warth A, Schnabel PA, Dienemann H, Schadendorf D, Hoffmann H, Umansky V.

J Thorac Oncol. 2011 Mar;6(3):432-8. doi: 10.1097/JTO.0b013e31820b80ca.

10.

The intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues.

Ling A, Edin S, Wikberg ML, Öberg Å, Palmqvist R.

Br J Cancer. 2014 May 13;110(10):2551-9. doi: 10.1038/bjc.2014.161. Epub 2014 Mar 27.

11.

Significance of immunoregulatory T cells in different stages of breast cancer patients.

Abo-Elenein A, Elgohary SE, Hashish A, El-Halaby E.

Egypt J Immunol. 2008;15(2):145-52.

PMID:
20306697
12.

Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1.

Yuan XL, Chen L, Zhang TT, Ma YH, Zhou YL, Zhao Y, Wang WW, Dong P, Yu L, Zhang YY, Shen LS.

World J Gastroenterol. 2011 Apr 21;17(15):2019-27. doi: 10.3748/wjg.v17.i15.2019.

13.

Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.

Katz SC, Bamboat ZM, Maker AV, Shia J, Pillarisetty VG, Yopp AC, Hedvat CV, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, DeMatteo RP.

Ann Surg Oncol. 2013 Mar;20(3):946-55. doi: 10.1245/s10434-012-2668-9. Epub 2012 Sep 26.

14.

CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer.

Mahalingam J, Lin CY, Chiang JM, Su PJ, Chu YY, Lai HY, Fang JH, Huang CT, Lin YC.

PLoS One. 2014 Sep 30;9(9):e108554. doi: 10.1371/journal.pone.0108554. eCollection 2014.

15.

Homeostasis of peripheral FoxP3(+) CD4 (+) regulatory T cells in patients with early and late stage breast cancer.

Rech AJ, Mick R, Kaplan DE, Chang KM, Domchek SM, Vonderheide RH.

Cancer Immunol Immunother. 2010 Apr;59(4):599-607. doi: 10.1007/s00262-009-0780-x. Epub 2009 Oct 24.

PMID:
19855964
16.

Determination of a CD4+CD25-FoxP3+ T cells subset in tumor-draining lymph nodes of colorectal cancer secreting IL-2 and IFN-γ.

Jafarinia M, Mehdipour F, Hosseini SV, Ghahramani L, Hosseinzadeh M, Ghaderi A.

Tumour Biol. 2016 Nov;37(11):14659-14666. Epub 2016 Sep 13.

PMID:
27619682
17.

Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.

Sobel ES, Brusko TM, Butfiloski EJ, Hou W, Li S, Cuda CM, Abid AN, Reeves WH, Morel L.

Arthritis Res Ther. 2011 Jun 27;13(3):R106. doi: 10.1186/ar3387.

18.

T-regulatory lymphocytes in peripheral blood of gastric and colorectal cancer patients.

Szczepanik AM, Siedlar M, Sierzega M, Goroszeniuk D, Bukowska-Strakova K, Czupryna A, Kulig J.

World J Gastroenterol. 2011 Jan 21;17(3):343-8. doi: 10.3748/wjg.v17.i3.343.

19.

High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer.

Hanke T, Melling N, Simon R, Sauter G, Bokemeyer C, Lebok P, Terracciano LM, Izbicki JR, Marx AH.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8227-35. eCollection 2015.

20.

Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients.

Deng L, Zhang H, Luan Y, Zhang J, Xing Q, Dong S, Wu X, Liu M, Wang S.

Clin Cancer Res. 2010 Aug 15;16(16):4105-12. doi: 10.1158/1078-0432.CCR-10-1073. Epub 2010 Aug 3.

Supplemental Content

Support Center